Clinical Pathways in Neuro-ophthalmology : An ... - E-Lib FK UWKS

112 Clinical Pathways in Neuro-Ophthalmology, second edition
Cullen JF. (1967). Occult temporal arteritis. A common cause of blindness in old age. Br J Ophthalmol 51:513–525.
Cullen JF, Coleiro JA. (1976). Ophthalmic complications of giant cell arteritis. Surv Ophthalmol 20:247–260.
Currey J. (1997). Scalp necrosis in giant cell arteritis and review of the literature. Br J Rheumatol 36:814–816.
Danesh-Meyer HV, Savino PJ, Eagle RC Jr, et al. (2000). Low diagnostic yield with second biopsies in suspected
giant cell arteritis. J Neuro-ophthalmol 20:213–215.
Danesh-Meyer HV, Savino PJ, Sergott RC. (2001). The prevalence of cupping in end-stage arteritic and nonarteritic
anterior ischemic optic neuropathy. Ophthalmology 108:593–598.
de Heide LJ, Talsma MA. (1999). Giant-cell arteritis presenting as an orbital pseudotumor. Neth J Med 55:196–198.
Delecoeullerie G, Joly P, DeLara AC, et al. (1988). Polymyalgia rheumatica and temporal arteritis: a retrospective
analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann
Rheum Dis 47:733–739.
Dennis RH II, Ransome JR. (1996). Giant cell arteritis presenting as a carpal tunnel syndrome. J Natl Med Assoc
88:524–525.
DeSilva M, Hazleman BL. (1986). Azathioprine in giant cell arteritis=polymyalgia rheumatica: a double-blind
study. Ann Rheum Dis 45:136–138.
Desmet GD, Knockaert DC, Bobbaers HJ. (1990). Temporal arteritis: the silent presentation and delay in diagnosis.
J Intern Med 227:237–240.
Desmond J, Hussain ST, Colin JF. (1999). Giant cell arteritis as a cause of intermittent claudications. Hosp Med
60:302.
de Vita S, Tavoni A, Jeracitano G, Gemignani G, Dolcher MP, Bombardieri S. (1992). Treatment of giant cell
arteritis with cyclophosphamide pulses (letter). J Intern Med 232:373–375.
Diamond JP. (1991). Treatable blindness in temporal arteritis. Br J Ophthalmol 75:432.
Diamond JP. (1993). IV steroid treatment in giant cell arteritis (letter). Ophthalmology 100:291–292.
DiBartolomeo AG, Brick JE. (1992). Giant cell arteritis and polymyalgia rheumatica. Postgrad Med 91:107–109.
Dick AD, Millar A, Johnson N. (1991). Brainstem vascular accidents and cranial arteritis. Scott Med J 36:85.
Diego M, Margo CE. (1998). Postural vision loss in giant cell arteritis. J Neuro-ophthalmol 18:124–126.
Egge K, Midtbo A, Westby R. (1996). Arteritis temporalis. Acta Ophthalmol 44:49–56.
Eggenberger E. (1998). Eight-and-a-half syndrome: one-and-a-half syndrome plus cranial nerve VII palsy.
J Neuroophthalmol 18:114–116.
Ellis JD, Munro P, McGettrick P. (1994). Blindness with a normal erythrocyte sedimentation rate in giant cell
arteritis. Br J Hosp Med 52:358–359.
Evans JM, Batts KP, Hunder GG. (1994). Persistent giant cell arteritis despite corticosteroid treatment. Mayo Clin
Proc 69:1060–1061.
Evans JM, O’Fallon WM, Hunder GG. (1995). Increased incidence of aortic aneurysm and dissection in giant cell
(temporal) arteritis. A population-based study. Ann Intern Med 122:502–507.
Evans JM, Vukov LF, Hunder GG. (1993). Polymyalgia rheumatica and giant cell arteritis in emergency
department patients. Ann Emerg Med 22:1633–1635.
Fernandez-Herlihy L. (1988). Temporal arteritis: clinical aids to diagnosis. J Rheumatol 15:1797.
Fife A, Dorrell L, Snow MH, Ong EL. (1994). Giant cell arteritis—a cause of pyrexia of unknown origin. Scott Med J
39:114–115.
Finelli PF. (1997). Alternating amaurosis fugax and temporal arteritis. Am J Ophthalmol 123:850–851.
Fineman MS, Savino PJ, Federman JL, Eagle RC, Jr. (1996). Branch retinal artery occlusion as the initial sign of
giant cell arteritis. Am J Ophthalmol 122:428–430.
Freddo T, Price M, Kase C, Goldstein MP. (1999). Myocardial infarction and coronary artery involvement in giant
cell arteritis. Optom Vis Sci 76:14–18.
Gabriel S, Espy M, Erdman DD, et al. (1999). The role of parvovirus B19 in the pathogenesis of giant cell arteritis.
A preliminary evaluation. Arthritis Rheum 42:1255–1258.
Gabriel SE, O’Fallon WM, Achkar AA, Lie JT, Hunder GG. (1995). The use of clinical characteristics to predict the
results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 22:93–96.
Galetta SL, Balcer LJ, Lieberman AP, et al. (1997a). Refractory giant cell arteritis with spinal cord infarction.
Neurology 49:1720–1723.
Galetta SL, Balcer LJ, Liu GT. (1997b). Giant cell arteritis with unusual flow-related neuro-ophthalmologic
manifestations. Neurology 49:1463–1465.
Galetta SL, Raps EC, Wulc AE, et al. (1990). Conjugal temporal arteritis. Neurology 40:1839–1842.
Garcia Vazquez JM, Carreira JM, Seoane C, Vidal JJ. (1999). Superior and inferior limb ischemia in giant cell
arteritis: angiography follow-up. Clin Rheumatol 18:61–65.
Gaynes BI. (1994). Occult giant cell arteritis: a diagnosis of suspicion. J Am Optom Assoc 65:564–571.